Align Technology (ALGN) : The consensus on Align Technology (ALGN) based on 9 analyst recommendation on the company stock is 1.06, which is interpreted as a Strong Buy recommendation. Zacks Investment Research has issued a rank of 2 which endorses a Buy on the stock. However, 8 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 1 analyst believes that the stock is a Buy, which can produce decent returns in the future.
Align Technology (ALGN) stock is expected to deviate a maximum of $9.04 from the average target price of $100.25 for the short term period. 8 Street Experts have initiated coverage on the stock with the most promising target being $115 and the most muted being $93.
For this week, the average consensus of the company shares are rated as a Strong Buy. Also, In a research note released to the investors, Stifel Nicolaus maintains its rating on Align Technology (NASDAQ:ALGN).The analysts at the brokerage house have a current rating of Buy on the shares. In a recent information released to the investors, Stifel Nicolaus raises the new price target from $82 per share to $95 per share. The rating by the firm was issued on July 28, 2016.
Align Technology (NASDAQ:ALGN): The stock opened at $95.38 and touched an intraday high of $96.48 on Wednesday. During the day, the stock corrected to an intraday low of $95.38, however, the bulls stepped in and pushed the price higher to close in the green at $96.29 with a gain of 1.08% for the day. The total traded volume for the day was 819,864. The stock had closed at $95.26 in the previous trading session.
Align Technology, Inc. (Align) is a medical device company. The Company designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services for dentistry, orthodontics, and dental records storage. The Company operates through two segments: Clear Aligner, known as the Invisalign system, and Scanners and Services, known as the iTero intraoral scanner and OrthoCAD services. The Companys Clear Aligner segment provides malocclusion and orthodontic treatment. The Companys Scanners and Services Segment offers iTero intraoral scanner, which utilizes laser and optical scanning to capture the contours of the patients dentition, gingival structures and the bite. It distributes products directly to customers, including orthodontists and general practitioner dentists (GPs), as well as to restorative dentists, including prosthodontists, periodontists and oral surgeons.